Av
Avanir (Otsuka)
Aliso Viejo CAFounded 1988200 employees
Private CapbiotechAcquiredCNS
Platform: Nuedexta PBA
Market Cap
N/A
All Drugs
3
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| AVA-8598 | AVA-8598 | Phase 2/3 | 1 | CD38 | CeliacParkinson's | ||
| Zorizasiran | AVA-5792 | Phase 1 | 1 | CD19 | HNSCCLGS | ||
| Zenovorutinib | AVA-615 | Preclinical | 1 | Cl18.2 | Endometrial Ca |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)